Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04206852

Safety and Efficacy of Balloon Pulmonary Angioplasty in China

Sponsor: Chinese Pulmonary Vascular Disease Research Group

View on ClinicalTrials.gov

Summary

Balloon pulmonary angioplasty (BPA) is a potential treatment for patients with pulmonary artery stenosis, including non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH), takayasu arteritis and fibrosis mediastinitis. The aim of this study was to evaluate the safety and efficacy of BPA in CTEPH and patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA, , takayasu arteritis and fibrosis mediastinitis.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2018-05-11

Completion Date

2065-05-11

Last Updated

2026-09-24

Healthy Volunteers

No

Interventions

PROCEDURE

Balloon pulmonary angioplasty

Balloon pulmonary angioplasty is an interventional technique where a balloon catheter is used to recanalize affected segments of pulmonary arteries identified during angiography.

Locations (2)

center of pulmonary vascular disease, Fuwai hospital

Beijing, China

Chinese Academy of Medical Sciences Fuwai hospital

Beijing, China